Invivyd LIBERTY Phase 3: VYD2311 Shows Superior Safety vs mRNA Vaccine; BLA Plans

Invivyd announced LIBERTY Phase 3 topline results showing VYD2311 safety and tolerability clinically and statistically superior to an mRNA COVID-19 vaccine and plans regulatory submissions for VYD2311.Key Highlights:Original SEC Filing: Invivyd, Inc. [ IVVD ] - 8-K - Sep. 29, 2026This is an AI-powe…